Become MBST License Partner*

MBST International · Exklusive partners · Long-term cooperation

Based on the experiences made in many years of marketing, distribution and application of the MBST therapy systems in Germany, MedTec has developed an independent MBST marketing system for international partners. Our exclusive partners get the opportunity to establish the worldwide patented MBST magnetic resonance technology in their home countries. They also have the right to run MBST centres for the purpose of treatments, distribution, demonstration, technical service and information.

MedTec is a strong partner who does not only offer technological expertise but also supports licensees and customers around the globe with strategies for distribution, trainings, marketing activities and country-specific consulting. MedTec sets standards in its models of business and customer service ranging from installation, technical service and inspections up to trainings and consulting.

To guarantee reliability and quality, the MBST magnetic resonance therapy is only applicated after diagnosis by medical professionals and solely in MBST treatment centres that have been certified by MedTec or by third parties authorised by MedTec. The objective of our certification systems is to provide the best possible, individualised and safe therapy for MBST patients. Basis for the certification are annual inspections that the MBST treatment centre and the medical staff have to pass successfully. They guarantee that the requirements for the optimal application of the MBST therapy and usage of the MBST technology are fulfilled.

Musculoskeletal conditions · A growing health market

Musculoskeletal diseases are worldwide the leading cause of chronic pain, physical restrictions and a reduced quality of life. They are a huge burden for patients and relatives because physical capabilities and consequently the participation on activies of daily life can be severely restricted. A large proportion of the elderly population suffers from one or several musculoskeletal diseases. A consequence beside the complaints of the patients are considerable direct and indirect costs for the national health systems. This development goes on pretty much all around the globe.

MedTec rises to the challenge with the MBST magnetic resonance therapy

Many conventional therapy approaches are aimed primarily at the symptoms. Pain killers and anti-inflammatory drugs shall make the disease easier to bear for the patient. Some, however, can have severe side-effects. A degenerative disease such as osteoarthritis or osteoporosis progresses, the diseased or damaged tissue decreases and at the end, the last option available might often be a surgical intervention with all associated risks.

Our choice of therapeutic products covers an immense market potential which will continue to grow with the ongoing demographic change. Musculoskeletal diseases become more and more common with advancing age. About 50% of the female and 33% of the male population between the age of 70 and 79 suffer from osteoarthritis. 25% of the women and 3% of the men in this age group suffer from osteoporosis. About 25% of the female and 17% of the male total population in Germany have chronic back pain. Many even suffer from several musculoskeletal diseases. Musculoskeletal diseases also figure prominently in inpatient treatment, being the cause for 9% of all inpatient hospitalisations in 2013. They are the most common diagnosis in health clinics and rehab centres for both genders, the most common reason for sick leave days and the second most common cause for health-related early retirement.

Health · Made in Germany · Successful worldwide

Since the business formation in 1998, MedTec is tipped for success and registers significant increases in sales. This is not at least due to our tried and tested business model that has proven successful in the long term and worldwide which we are continuously optimizing. It enables a fast entry into the market and a high rentability for our partners. It is not for nothing that today we are present in more than 500 locations in more than 40 countries – and still growing.

Do you identify with the concept of the MBST system? Are you looking for an investment opportunity? Can you imagine your future in the field of medical technology? Then get started with us. Order information about our company and the many advantages of our MBST systems as well as the available license areas. Take the next step and get in contact with MedTec Medizintechnik.